Clinical Trial

Early Identification of Heart Failure in a High-Risk Diabetic Cohort

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Type 2 diabetes is an important co-morbid condition strongly associated with the risk of developing heart failure (HF). Risk scores such as the WATCH-DM score that predict the occurrence of HF among diabetes patients are largely based on data collected from white ethnicities. Here, the investigators sought to investigate surrogate markers for predicting HF among type 2 diabetes patients of Asian ethnicities.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-05-17; most recent amendment 2025-04-13.
Status change: Recruiting → Active, Not Recruiting 2024-11-18
Trial Details
NCT Number NCT05866380
Lead Sponsor Mackay Memorial Hospital
Conditions Type2diabetes
Enrollment 3,500 participants
Start Date 2022-03-23
Primary Completion 2025-03-01 (estimated)
Study Completion 2025-05-31 (estimated)
Updated on ClinicalTrials.gov 2025-04-15